Chasing that ‘Time magazine cover potential’
PharmaVoice
NOVEMBER 8, 2022
Rami Elghandour was already retired. Then CAR-T specialist Arcellx lured him back into the industry to try to change the world.
PharmaVoice
NOVEMBER 8, 2022
Rami Elghandour was already retired. Then CAR-T specialist Arcellx lured him back into the industry to try to change the world.
Fierce Pharma
NOVEMBER 15, 2023
The craze is such that Germany’s drug regulator is considering banning the export of Ozempic, according to a report in Der Spiegel magazine. | How popular have Novo Nordisk’s semaglutide drugs become for weight loss in Europe?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 26, 2024
In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.
Pharmaceutical Technology
JULY 1, 2022
The post Magazine-How delays derailed Covid-19 vaccination in Africa appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.
Pharmaceutical Technology
FEBRUARY 2, 2023
The post Magazine: CRISPR gene therapies cut through in 2023 appeared first on Pharmaceutical Technology. Read the latest issue of Pharma Technology Focus for all this and more news, insights, and analysis from the pharmaceutical industry. You can also subscribe here to receive email notifications when a new issue is available.
Pharmaceutical Technology
NOVEMBER 22, 2022
The post Magazine: What Rishi Sunak can do for the UK pharma industry appeared first on Pharmaceutical Technology. All this, and the latest pharma industry news , comment, data, and analysis from GlobalData. Click here to view the latest issue of Pharmaceutical Technology Focus.
Pharmaceutical Technology
JULY 31, 2024
Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.
Let's personalize your content